Aug 27, 2019
FDA approves new add-on drug to treat off episodes in adults with Parkinson's disease
Jul 24, 2019
Parkinson's Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Jul 22, 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Jul 01, 2019
Intec Pharma Announces Publication of Article Reviewing Accordion Pill's Unique Gastric Retention Platform in Therapeutic Delivery
Oct 24, 2018
Amneal Announces Issuance of New Patent for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa
May 07, 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
Apr 04, 2018
Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting
Mar 26, 2018
Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors
Mar 12, 2018
Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson's Disease
Nov 08, 2017
Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference
Oct 26, 2017
Intec Pharma Names Walt Linscott as Chief Administrative Officer
Oct 06, 2017
Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit
Aug 21, 2017
Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares